Comparison of action of the anti-neoplastic drug lonidamine on drug-sensitive and drug-resistant human breast cancer cells:31 P and 13C nuclear magnetic resonance studies-Reference-Cited by-同舟云学术

Comparison of action of the anti-neoplastic drug lonidamine on drug-sensitive and drug-resistant human breast cancer cells:31 P and 13C nuclear magnetic resonance studies

Published:1997-03 Issue:1 Volume:43 Page:15-25
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Vivi Antonio,Tassini Maria,Ben-Horin Hava,Navon Gil,Kaplan Ofer

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.springerlink.com/index/pdf/10.1023/A:1005781320906

Reference41 articles.

1. Moscow JA, Cowan KH: Multidrug resistance. J Natl Cancer Inst 80: 14–20, 1988

2. Bernard J, Bourhis J, Riou G: Clinical significance of multidrug resistance in human cancers. Anticancer Res 10: 1297–1302, 1990

3. Townsend AJ, Cowan KH: Glutathione S-transferases an antineoplastic drug resistance. Cancer Bull 41: 31–37, 1989

4. Patel NH, Rothenberg ML: Multidrug resistance in cancer chemotherapy. Invest New Drugs 12: 1–13, 1994

5. Kaplan O, Van-Zijl PCM, Cohen JS: Information from combined 1H and 31P NMR studies of cell extracts: Differences in metabolism between drug-sensitive and drug-resistant MCF-7 human breast cancer cells. Biochem Biophys Res Commun 169: 383–390, 1990

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-cell NMR: Why and how?;Progress in Nuclear Magnetic Resonance Spectroscopy;2022-10

2. Pharmacological interventions part III;An Innovative Approach to Understanding and Treating Cancer: Targeting pH;2020

3. MRI and MRS of intact perfused cancer cell metabolism, invasion, and stromal cell interactions;NMR in Biomedicine;2019-01-28

4. The Typical Metabolic Modifiers Conferring Improvement in Cancer Resistance;Current Medicinal Chemistry;2017-11-17

5. Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer;Current Medicinal Chemistry;2017-06-22